Interventional technology firm Medtronic of Minneapolis has unveiled a number of management changes to spur growth heading into its fourth fiscal quarter.
COO Michael DeMane has left the company to pursue other opportunities. No successor was immediately named.
Jean-Luc Butel, president of Medtronic's Asia Pacific region, has been named president of Medtronic International. He will be responsible for all Medtronic operations outside of the U.S.
Katie Szyman, formerly vice president of Medtronic Endovascular, has been named senior vice president of a newly formed strategy and development group that combines the company's corporate strategy, business development, corporate ventures, and science and technology functions.
Steve LaNeve, formerly president of Medtronic Japan, has been named president of Medtronic's Spinal and Biologics business. He replaces Pete Wehrly, who is leaving the company.
Bob Blankemeyer, vice president and general manager of Medtronic ENT/NT, assumes additional responsibility for Medtronic Navigation.
Related Reading
MediGuide, Medtronic ink deal, January 28, 2008
Medtronic to begin testing MRI-safe pacemaker, January 28, 2008
Medtronic launches stent graft product, January 10, 2008
Medtronic begins Endurant trial, December 17, 2007
Medtronic completes PMA filing for Talent, December 3, 2007
Copyright © 2008 AuntMinnie.com
